甲状腺未分化がん(Anaplastic Thyroid Cancer):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2582CTIDB
◆発行会社(調査会社):GlobalData
◆発行日:2015年2月27日
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における甲状腺未分化がん(Anaplastic Thyroid Cancer) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 甲状腺未分化がん(Anaplastic Thyroid Cancer)
  - 当レポートの概要
・甲状腺未分化がん(Anaplastic Thyroid Cancer):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015″ provides data on the Anaplastic Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Anaplastic Thyroid Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Anaplastic Thyroid Cancer 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
OXiGENE, Inc. 33
Clinical Trial Overview of OXiGENE, Inc. 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Daiichi Sankyo Company, Limited 36
Clinical Trial Overview of Daiichi Sankyo Company, Limited 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Genelux Corporation 38
Clinical Trial Overview of Genelux Corporation 38
Clinical Trial Overview of Top Institutes / Government 39
National Cancer Institute 39
Clinical Trial Overview of National Cancer Institute 39
Case Comprehensive Cancer Center 40
Clinical Trial Overview of Case Comprehensive Cancer Center 40
Memorial Sloan Kettering Cancer Center 41
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 41
Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino 42
Clinical Trial Overview of Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino 42
University of Schleswig-Holstein 43
Clinical Trial Overview of University of Schleswig-Holstein 43
University of Colorado 44
Clinical Trial Overview of University of Colorado 44
University of Michigan Comprehensive Cancer Center 45
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 45
University of Kentucky 46
Clinical Trial Overview of University of Kentucky 46
Leiden University Medical Center 47
Clinical Trial Overview of Leiden University Medical Center 47
Five Key Clinical Profiles 48
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Anaplastic Thyroid Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Anaplastic Thyroid Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Anaplastic Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015* 33
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 35
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 36
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genelux Corporation, 2015* 38
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 39
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 40
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 41
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino, 2015* 42
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2015* 43
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 44
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2015* 45
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 46
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 47

List of Figures
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 78

【レポートのキーワード】

甲状腺未分化がん(Anaplastic Thyroid Cancer)、治験、臨床試験、治験、治療薬

★調査レポート[甲状腺未分化がん(Anaplastic Thyroid Cancer):世界の治験レビュー(2015年上半期版)] (コード:GDHC2582CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[甲状腺未分化がん(Anaplastic Thyroid Cancer):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆